The value of serum tissue polypeptide specific antigen in the diagnosis of hepatocellular carcinoma

Cancer

Volumn 85, Issue 5, 1999, Pages 1039-1043

  Tu, Dom Gene ^a   Wang, Shan Tair ^b   Chang, Ting Tsung ^a   Chiu, Nan Tsing ^a   Yao, Wei Jen ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

fetoprotein; Diagnosis; Hepatocellular carcinoma; Tissue polypeptide specific antigen; Tumor marker

Indexed keywords

TISSUE POLYPEPTIDE ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ALPHA-FETOPROTEINS; ANTIGENS, NEOPLASM; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PEPTIDES; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0032967477     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990301)85:5<1039::AID-CNCR5>3.0.CO;2-B     Document Type: Article

References (30)

1. Beasley RP. Hepatitis B virus, the major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
2. Shinagawa T, Ohto M, Kimura K, Tsunetomi S, Morita M, Saisho H, et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography: a study in 51 patients. Gastroenterology 1984;86:495-502.
3. Chen DS, Sung JL, Sheu JC, Lai MY, How SW, Hsu HC, et al. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology 1984;86:1404-9.
4. Sheu JC, Sung JL, Chen DS, Lai MY, Wang TH, Yu JY, et al. Early detection of hepatocellular carcinoma by real-time ultrasonography: a prospective study. Cancer 1985;56:660-6.
5. Chen DS, Sung JL. Serum alpha-fetoprotein in hepatocellular carcinoma. Cancer 1977;40:779-83.
6. Lai CL, Gregory PB, Wu PC, Lok AS, Wang KP, Ng MM. Hepatocellular carcinoma in Chinese males and females: possible causes for the male predominance. Cancer 1987;60: 1107-10.
7. Sakon M, Monden M, Gotoh M, Kanai T, Umeshita K, Nakano Y, et al. Relationship between pathologic prognostic factors and abnormal level of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma. Am J Surg 1992;163:251-6.
8. Kuromatsu R, Tanaka M, Tanikawa K. Serum alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma. Liver 1993;13:177-82.
9. Taketa K, Endo Y, Sekiya C, Tanikawa K, Koji T, Hirai H, et al. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res 1993;53:5419-23.
10. Bjorklund B, Bjorklund V. Antigenicity of pooled human malignant and normal tissue by cytoimmunological techniques: presence of an insoluble, heat-labile tumor antigen. Int Arch Allergy Immunol 1957;10:153-84.
11. Bjorklund B, Bjorklund V, Brunkener M, Gronlund H, Back M. The enigma of a human tumor markers: TPA revised. In: Climino F, Birkmayer GD, Klavins JV, Pimentel E, Salvatore F, editors. Human tumor markers. Berlin: Walter de Gruyter, 1987:169-80.
12. Einarsson R, Rydlander L. Tissue polypeptide specific antigen (TPS) detects a specific epitope structure on human cytokeratin. Anticancer Res 1997;17:3121-4.
13. Madersbacher S, Gregor N, Theyer G, Steiner G, Marberger M. TPS is a useful epithelial proliferation and tumor marker. J Urol 1992;147:A911.
14. Livraghi T, Vettori C. Percutaneous ethanol injection therapy of hepatoma. Cardiovasc Intervent Radiol 1990;13: 135-9.
15. Plebani M, Basso D, Del Favero G, Ferrara C, Meggiato T, Fogar P, et al. Clinical utility of TPS, TPA and CA 19-9 measurement in pancreatic cancer. Oncology 1993;50:436-40.
16. Tarle M, Kovacic K, Kastelan M. Correlation of cell proliferation marker (TPS), nature killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors. Anticancer Res 1993;13:215-8.
17. Stieber P, Dienemann H, Hasholzner U, Muller C, Poley S, Hofmann K, et al. Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumor markers in lung cancer. Eur J Clin Chem Clin Biochem 1993;31:689-94.
18. Kornek G, Schenk T, Raderer M, Djavarnmad M, Scheithauer W. Tissue polypeptide specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumor. Br J Cancer 1995;71:182-5.
19. Bremer K, Eklund G, Bjorklund B. Notable relationship between the level of tumor marker TPS in serum and survival in breast cancer. Anticancer Res 1996;16:905-10.
20. Martin M, Rayo JI, Talavera JR, Munoz A, Canizo A. Evaluation of serum tumor marker in head and neck cancer. J Nucl Med Allied Sci 1990;34(4 Suppl):235-8.
21. van Dalen A. TPS in breast cancer: a comparative study with carcinoembryonic antigen and CA 15-3. Tumour Biol 1992; 13:10-7.
22. Yao WJ, Chang CJ, Chan SH, Chow NH, Cheng HL, Tzai TS, et al. Significance of urinary tissue polypeptide specific antigen (TPS) determination in patients with urothelial carcinoma. Anticancer Res 1995;15:2819-23.
23. Gibsons JD. Nonparametric statistical inference. 2nd edition. New York: Marcel Dekker, 1985.
24. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
25. Hanley JA, McNeil BJ. A method of comparing the area under receiver operating characteristic curve derived from the same cases. Radiology 1983;148:839-43.
26. Kew MC, Berger EL. The value of serum concentration of tissue polypeptide antigen in the diagnosis of hepatocellular carcinoma. Cancer 1986;58:127-30.
27. Leandro G, Zizzari S, Piccolli A, Manghisi OG. The serum tissue polypeptide antigen in the detection of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 1990;37:449-51.
28. Gallo V, Cerutti E, Riberi A, Re M, Petrino R, Pecchio F. Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorder. J Nucl Med Allied Sci 1989;33(3 Suppl):89-93.
29. Collazos J, Genolla J, Ruibal A. A clinical and laboratory evaluation of the behavior of tissue polypeptide antigen in liver cirrhosis. Digestion 1992;53:157-61.
30. Kao CH, Gu CJ, Wang SJ. Tissue polypeptide specific antigen in hepatitis B carriers. Anticancer Res 1994;14: 2817-8.